News from insightec A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 02, 2019, 20:00 ET INSIGHTEC MR-Guided Focused Ultrasound Receives Reimbursement from Japanese Ministry of Health, Labour and Welfare for the Treatment of Essential Tremor

INSIGHTEC®, a global medical technology innovator of incisionless surgery, today announced that it has received national reimbursement from the...


Feb 25, 2019, 06:00 ET INSIGHTEC Announces Expansion of Positive Insurance Coverage for MR-guided Focused Ultrasound to Treat Essential Tremor

INSIGHTEC®, a global medical technology innovator of incisionless surgery, today announced that Noridian has posted a positive Local Coverage...


Dec 18, 2018, 15:21 ET INSIGHTEC Announces FDA Approval of Exablate Neuro for the Treatment of Tremor-Dominant Parkinson's Disease

INSIGHTEC®, a global medical technology innovator of incisionless surgery, today announced that The Center for Devices and Radiological Health (CDRH) ...


Oct 01, 2018, 09:00 ET INSIGHTEC's MR-Guided Focused Ultrasound Treatment for Essential Tremor Now Covered By Medicare in 25 States

Expansion of Medicare Coverage Gives a Growing Number of Patients Affordable Access INSIGHTEC®, a global medical technology innovator of incisionless ...


Jun 25, 2018, 02:30 ET El ultrasonido centrado de INSIGHTEC consigue una dirección positiva NICE para el tratamiento del tremor esencial

La talamotomía unilateral de ultrasonidos centrados guiada MRI para el tratamiento del tremor esencial resistente al tratamiento es reconocida por el ...


Jun 21, 2018, 03:30 ET Les ultrasons ciblés d'INSIGHTEC obtiennent une orientation NICE positive pour le traitement des tremblements essentiels

La thalamotomie par ultrasons ciblés guidés par IRM unilatérale pour les tremblements essentiels résistants aux traitements, reconnue par le National ...


Jun 21, 2018, 03:30 ET La tecnologia a ultrasuoni focalizzati di INSIGHTEC ottiene un giudizio positivo NICE per la cura del tremore essenziale

La talamotomia unilaterale a ultrasuoni focalizzati a guida MRI per il tremore essenziale refrattario alle cure è stata premiata dal National...


Jun 21, 2018, 03:18 ET INSIGHTECs fokussiertem Ultraschall werden positive NICE-Leitlinien für die Behandlung essentiellen Tremors zugesprochen

Unilaterale MRT-gestützte fokussierte Ultraschall-Thalamotomie für behandlungsresistenten essentiellen Tremor wird vom National Institute for Health...


May 14, 2018, 09:00 ET INSIGHTEC Submits Pre-market Approval to Japanese PMDA of MR-guided Focused Ultrasound Surgery for Treatment of Parkinson's Disease

INSIGHTEC®, a global medical technology innovator of incisionless surgery, today announced that it has submitted a Pre-Market Approval (PMA) to the...


May 02, 2018, 02:12 ET Focused Ultrasound Extends Its Focus: INSIGHTEC Initiates Parkinson's Disease Study With First Patient Treated With Incisionless Brain Surgery

INSIGHTEC®, a global medical technology innovator of incisionless surgery, today announced the treatment of its first patient in the FDA pivotal...


Apr 13, 2018, 09:00 ET Exablate Neuro From INSIGHTEC Takes Top Honor at Edison Awards

MIAMI, April 13, 2018 INSIGHTEC®, a global medical technology innovator of incisionless surgery, today announced that its Exablate Neuro™ focused...


Feb 20, 2018, 09:00 ET Israel Ministry of Health Includes INSIGHTEC's Focused Ultrasound Treatment for Medication-Refractory Essential Tremor as Part of Covered Health Services

INSIGHTEC®, a commercial-stage medical technology company revolutionizing surgery with incisionless MR-guided focused ultrasound (MRgFUS) announced...


Jan 31, 2018, 08:30 ET INSIGHTEC Closes $150 Million Series E Financing

INSIGHTEC®, a commercial-stage medical technology company revolutionizing surgery with incisionless MRI-guided focused ultrasound (MRgFUS) announced...


Nov 29, 2017, 08:00 ET Insightec: The Taiwanese Food and Drug Administration (TFDA) Approved Exablate Neuro for the Treatment of Essential Tremor

INSIGHTEC, the leader in MR-guided Focused Ultrasound (MRgFUS) therapy, announced today that the Taiwanese Food and Drug Administration (TFDA) has...


Nov 27, 2017, 08:00 ET FDA Approves First Study of INSIGHTEC's Exablate Neuro to Open the Blood-Brain Barrier in Glioblastoma Patients

INSIGHTEC, the world leader of MR-guided Focused Ultrasound announced today that it has received approval from the U.S. Food and Drug Administration...


Oct 27, 2017, 15:16 ET INSIGHTEC's Exablate Neuro Named Best Medical Technology at Esteemed Prix Galien Awards 2017

INSIGHTEC, the leader in MR-guided Focused Ultrasound (MRgFUS), has been awarded Best Medical Technology for Exablate Neuro by The Galien Foundation. ...


Oct 25, 2017, 09:00 ET INSIGHTEC Receives FDA Approval to Initiate Pivotal Study of Exablate Neuro for the Treatment of Patients with Parkinson's Disease

INSIGHTEC, the world leader of MR-guided Focused Ultrasound announced today that it has received approval from the U.S. Food and Drug Administration...


Aug 16, 2017, 08:00 ET INSIGHTEC Announces Expanded Reach of MR-Guided Focused Ultrasound

INSIGHTEC announced today that worldwide adoption of MR-guided focused ultrasound continues to gain momentum as Exablate Neuro patient treatment...


May 09, 2017, 09:00 ET INSIGHTEC Receives FDA Approval for Exablate Neuro for 1.5T MRI in the Treatment of Essential Tremor

INSIGHTEC, the leader in MR-guided Focused Ultrasound (MRgFUS), announced today that the FDA has approved its Exablate Neuro (Model 4000) system for...


Apr 20, 2017, 12:30 ET INSIGHTEC: First Patient with Benign Brain Tumor has Focused Ultrasound Procedure at Nicklaus Children’s Hospital

INSIGHTEC congratulates Nicklaus Children's Hospital, part of the Miami Children's Health System, for performing the first focused ultrasound...


Mar 03, 2017, 03:00 ET INSIGHTEC informiert: Operationsersetzende innovative Behandlungsmethode "MRT-gestützter Einsatz von hochfokussiertem Ultraschall" (MRgFUS) bei Uterusmyomen: Erstmalig tritt Richtlinie zur Verfahrenserprobung nach §137e SGB V in Kraft

Der Gemeinsame Bundesausschuss (G‑BA) hat am 15.12.2016 seine erste Richtlinie zur Erprobung einer neuen Behandlungsmethode auf Antrag eines...


Dec 21, 2016, 03:00 ET INSIGHTEC ottiene il marchio CE per Exablate Prostate per il trattamento locale del tumore della prostata

INSIGHTEC Ltd. ha annunciato che il sistema Exablate Prostate ha ottenuto il marchio CE per il trattamento locale del tumore della prostata con...


Dec 21, 2016, 03:00 ET INSIGHTEC erhåller CE-märkning av Exablate Prostate för behandling av lokaliserad prostatacancer

INSIGHTEC Ltd. meddelade idag att Exablate Prostate-systemet erhållit CE-märkning för behandling av lokaliserad prostatacancer med riktad...


Dec 21, 2016, 03:00 ET INSIGHTEC reçoit le marquage CE pour le système Exablate Prostate pour le traitement des cancers confinés à la prostate

INSIGHTEC Ltd. a annoncé aujourd'hui que le système Exablate Prostate a reçu le marquage CE pour le traitement du cancer confiné à la prostate, avec...


Dec 21, 2016, 03:00 ET INSIGHTEC recibe la marca CE para Exablate Prostate para tratar localmente el cáncer de próstata localizado

INSIGHTEC Ltd. anunció hoy que el sistema Exablate Prostate recibió la marca CE para el tratamiento del cáncer de próstata localmente confinado con...